Overview
- 197 inspections across 161 sites are on record.
- 210 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-21.
At a glance
Inspections
197
Sites
161
Observations
210
Career since
Feb 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Jo-Anne H. Young, MD, FACP | 21 May 2026 | Biologics | |
| William A. Faubion, Jr., M.D. | 7 May 2026 | Biologics | |
| David Roberge, MD | 17 Apr 2026 | Medical Devices & Rad Health | |
| Milla Pharmaceuticals, Inc. | 12 Mar 2026 | Human Drugs | On file |
| Upsher-Smith Laboratories, LLC | 10 Feb 2026 | Human Drugs |
Sites inspected
Jo-Anne H. Young, MD, FACPMinneapolis, United States1 insp.
William A. Faubion, Jr., M.D.Rochester, United States1 insp.
David Roberge, MDMontreal, Canada1 insp.
Milla Pharmaceuticals, Inc.Saint Paul, United States1 insp.
Upsher-Smith Laboratories, LLCMaple Grove, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Nicole C Victoria6 shared
Tara C Singh6 shared
Aimee J Edwin5 shared
Kellie L Thommes4 shared
Ralph W Jerndal3 shared
Jaclyn N Munsch3 shared
Rene R Ramirez2 shared
Mada A Tautges2 shared
Denise L Burosh2 shared
Kathryn Suttling1 shared
Full investigator report
Get the verbatim findings behind Sharon L Matson's 210 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site